ApoA-I knockout mice: Characterization of HDL metabolism in homozygotes and identification of a post-RNA mechanism of apoA-I up-regulation in heterozygotes

Journal of Lipid Research

Volumn 38, Issue 5, 1997, Pages 1033-1047

  Plump, Andrew S ^a   Azrolan, Neal ^a,b   Odaka, Hiroyuki ^a   Wu, Lin ^a   Jiang, Xian ^a,c   Tall, Alan ^a,c   Eisenberg, Shlomo ^a   Breslow, Jan L ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b PFIZER INC   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Apolipoprotein A I; Atherosclerosis; Cholesterol; Mouse; Reverse cholesterol transport

Indexed keywords

APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLESTEROL DIET; CHOLESTEROL METABOLISM; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; GENE TARGETING; GENETIC DISORDER; HETEROZYGOSITY; HOMOZYGOSITY; LIPOPROTEIN METABOLISM; METABOLIC DISORDER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN DETERMINATION;

ANIMALS; APOLIPOPROTEIN A-I; CHOLESTEROL; HETEROZYGOTE; HOMOZYGOTE; LIPOPROTEINS, HDL; MICE; MICE, KNOCKOUT; RNA, MESSENGER; UP-REGULATION;

EID: 0030982091     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Breslow, J. 1995. Disorders of HDL Metabolism. In The Metabolic Basis of Inherited Disease. C. A. Scriver, W. Sly, and D. Valle, editors. Seventh ed. Vol. 2. McGraw-Hill Book Company, New York. 2031-2052.
2. Glomset, J. 1968. The plasma lecithin:cholesterol acyltransferase reaction. J. Lipid Res. 9: 155-167.
3. Eisenberg, S. 1984. High density lipoprotein metabolism. J. Lipid Res. 25: 1017-1058.
4. Reichl, D., and N. Miller. 1989. Pathophysiology of reverse cholesterol transport. Insights from inherited disorders of lipoprotein metabolism. Arteriosclerosis. 9: 785-797.
5. Andersen, J., and J. Dietschy. 1978. Relative importance of high and low density lipoproteins in the regulation of cholesterol synthesis in the adrenal gland, ovary, and testis of the rat. J. Biol. Chem. 253: 9024-9032.
6. Gwynne, J., and B. Hess. 1980. The role of high density lipoproteins in rat adrenal cholesterol metabolism and steroidogenesis. J. Biol. Chem. 255: 10875-10883.
7. 3. J. Biol. Chem. 264: 6488-6494.
8. Rubin, E., B. Ishida, S. Clift, and R. Krauss. 1991. Expression of human apolipoprotein A-I in transgenic mice results in reduced plasma levels of murine apolipoprotein A-I and the appearance of two new high density lipoprotein size subclasses. Prof. Natl. Acad. Sci. USA. 88: 434-438.
9. Rubin, E. R., R. Krauss, E. Spangler, J. Verstuyft, and S. Clift. 1991. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein A-I. Nature. 353: 265-267.
10. Plump, A. S., C. Scott, and J. Breslow. 1994. Human apolipoprotein A-I gene expression increases high density lipoproteins and suppresses atherosclerosis in the apolipoprotein E-deficient mouse. Proc. Natl. Acad. Sci. USA. 91: 9607-9611.
11. Paszty, C., N. Maeda, J. Verstuyft, and E. Rubin. 1994. Apolipoprotein A-I transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice. J. Clin. Invest. 94: 899-903.
12. Williamson, R., D. Lee, J. Hagaman, and N. Maeda. 1992. Marked reduction of high density lipoprotein cholesterol in mice genetically modified to lack apolipoprotein A-I. Proc. Natl. Acad. Sci. USA. 88: 7134-7138.
13. Plump, A. S., T. Hayek, A. Walsh, and J. L. Breslow. 1993. Diminished HDL cholesterol ester flux in apoA-I-deficient mice. Circulation. 88: 2266a.
14. Hao, L., R. Reddick, and N. Maeda. 1993. Lack of apoA-I is not associated with increased susceptibility to atherosclerosis in mice. Arterioscler. Thromb. 13: 1814-1821.
15. Tybulewicz, V., C. Crawford, P. Jackson, R. Bronson, and R. Mulligan. 1991. Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell. 65: 1153-1163.
16. Agellon, L., A. Walsh, T. Hayek, P. Moulin, X. Jiang, S. Shelanski, J. Breslow, and A. Tall. 1991. Reduced high density lipoprotein cholesterol in human cholesteryl ester transfer protein transgenic mice. J. Biol. Chem. 266: 10796-10801.
17. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chlorofonn extraction. Anal. Biochem. 162: 156-159.
18. Azrolan, N., and J. Breslow. 1990. A solution hybridization/RNase protection assay with riboprobes to determine absolute levels of apoB, A-I, and E mRNA. J. Lipid Res. 31: 1141-1146.
19. Jiang, X., L. Masucci-Magoulas, J. Mar, M. Lin, A. Walsh, J. Breslow, and A. Tall. 1993. Down-regulation of mRNA for the low density lipoprotein receptor in transgenic mice containing the gene for human cholesteryl ester transfer protein. J. Biol. Chem. 268: 27406-27412.
20. Schultz, J., E. Gong, M. McCall, A. Nichols, S. Clift, and E. Rubin. 1993. Expression of human apolipoprotein A-II and its effect on high density lipoproteins in transgenic mice. J. Biol. Chem. 267: 21630-21636.
21. Lowry, O. H., N. J. Rosenbrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275.
22. Oschry, Y., and S. Eisenberg. 1982. Rat plasma lipoproteins: re-evaluation of a lipoprotein system in an animal devoid of cholesteryl ester transfer activity. J. Lipid Res. 23: 1099-1106.
23. Chajek-Shaul, T., T. Hayek, A. Walsh, and J. Breslow. 1991. Expression of the human apolipoprotein A-I gene in transgenic mice alters high density lipoprotein (HDL) particle size distribution and diminishes selective uptake of HDL cholesteryl esters. Proc. Natl. Acad. Sci. USA. 88: 6731-6735.
24. 131I-labeled plasma proteins. Phys. Med. Biol. 2: 36-53.
25. Hayek, T., Y. Ito, N. Azrolan, R. Verdery, K. Aalto-Setala, A. Walsh, and J. Breslow. 1993. Dietary fat increases HDL levels both by increasing the TR and decreasing the FCR of HDL CE and apoA-I: presentation of a new animal model and mechanistic studies in human apoA-I transgenic and control mice. J. Clin. Invest. 91: 1665-1671.
26. Azrolan, N., H. Odaka, J. Breslow, and E. Fisher. 1995. Dietary fat elevates hepatic apoA-I production by increasing the fraction of apoA-I mRNA in the translating pool. J. Clin. Invest. 270: 19833-19838.
27. Plump, A., S. Erickson, W. Weng, J. Partin, J. Breslow, and D. Williams. 1996. ApoA-I is required for cholesteryl ester accumulation in steroidogenic cells and for normal adrenal steroid production. J. Clin. Invest. 97: 2660-2671.
28. Stein, O., G. Halperin, and Y. Stein. 1980. Biological labelling of very low density lipoproteins with cholesteryl linoleyl ether and its fate in the intact rat. Biochim. Biophys. Acta. 602: 247-260.
29. Hayek, T., N. Azrolan, R. Verdery, A. Walsh, T. Chajek-Shaul, L. Agellon, A. Tall, and J. Breslow. 1993. Hypertriglyceridemia and cholesteryl ester transfer protein interact to dramatically alter high density lipoprotein levels, particle size, and metabolism. J. Clin. Invest. 92: 1143-1152.
30. Warden, C., C. Hedrick, J.-H. Qiao, L. Castellani, and A. Lusis. 1993. Atherosclerosis in mice overexpressing apolipoprotein A-II. Science. 261: 469-472.
31. Mehrabian, M., J.-H., Qiao, R. Hyman, D. Ruddle, C. Laughton, and A. Lusis. 1993. Influence of the apoA-II gene locus on HDL levels and fatty streak development in mice. Arterioscler. Thromb. 13: 1-10.
32. Zhong, S., I. Goldberg, C. Bruce, E. Rubin, J. Breslow, and A. Tall. 1994. Human apoA-II inhibits the hydrolysis of HDL triglyceride and the decrease of HDL particle size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic mice. J. Clin. Invest. 94: 2457-2467.
33. 2 subfractions with hepatic lipase. J. Lipid Res. 33: 1269-1279.
34. Jahn, C. E., J. J. C. Osborne, E. J. Schaefer, and H. B. Brewer, Jr. 1983. Activation of the enzymic activity of hepatic lipase by apolipoprotein A-II. Characterization of a major component of high density lipoprotein as the activating plasma component in vitro. Eur. J. Biochem. 131: 25-29.
35. Parks, J., J. Li, A. Gebre, T. Smith, and N. Maeda. 1995. Effect of apolipoprotein A-I deficiency on lecithin:cholesterol acyltransferase activation in mouse plasma. J. Lipid Res. 36: 349-355.
36. Schwartz, C., L. Halloran, Z. Vlahcevic, D. Gregory, and L. Swell. 1978. Preferential utilization of free cholesterol from high-density lipoproteins for biliary cholesterol secretion in man. Science. 200: 62-64.
37. Bravo, E., A. Cantafora, and L. Argiolas. 1989. Hepatic uptake and metabolism of free cholesterol from different lipoprotein classes. An in vivo study in the rat. Biochim. Biophys. Acta. 1003: 315-320.
38. Pieters, M., D. Schouten, H. Bakkeren, B. Esbach, A. Brouwer, D. Knook, and T. V. Berkel. 1991. Selective uptake of cholesteryl esters from apolipoprotein-E-free high-density lipoproteins by rat parenchymal cells in vivo is efficiently coupled to bile acid synthesis. Biochem. J. 280: 359-365.